Drug Shortage Report for RIVOTRIL
Report ID | 171580 |
Drug Identification Number | 00382841 |
Brand name | RIVOTRIL |
Common or Proper name | CLONAZEPAM |
Company Name | CHEPLAPHARM ARZNEIMITTEL GMBH |
Market Status | MARKETED |
Active Ingredient(s) | CLONAZEPAM |
Strength(s) | 2MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | Bottles of 100 tablets |
ATC code | N03AE |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-10-31 |
Actual start date | |
Estimated end date | 2023-03-31 |
Actual end date | 2023-03-31 |
Shortage status | Resolved |
Updated date | 2023-04-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | ZIEGELHOF 24 GREIFSWALD, MECKLENBURG - WEST POMERANIA GERMANY 17489 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2023-04-01 | English | Compare |
v12 | 2023-03-31 | French | Compare |
v11 | 2023-03-31 | English | Compare |
v10 | 2023-02-14 | French | Compare |
v9 | 2023-02-14 | French | Compare |
v8 | 2023-02-14 | English | Compare |
v7 | 2023-01-06 | French | Compare |
v6 | 2023-01-06 | English | Compare |
v5 | 2022-11-30 | French | Compare |
v4 | 2022-11-30 | English | Compare |
v3 | 2022-11-01 | English | Compare |
v2 | 2022-10-12 | French | Compare |
v1 | 2022-10-12 | English | Compare |
Showing 1 to 13 of 13